Explore

Trendline Trendline
Konovo's AI-Driven Approach Enhances Healthcare Panel Engagement

Konovo's AI-Driven Approach Enhances Healthcare Panel Engagement

Konovo's AI-Driven Approach Enhances Healthcare Panel Engagement
Trendline Trendline
Sage Introduces Tasking Solution with ALIS EHR Integration to Enhance Senior Living Care

Sage Introduces Tasking Solution with ALIS EHR Integration to Enhance Senior Living Care

Sage Introduces Tasking Solution with ALIS EHR Integration to Enhance Senior Living Care
Rapid Read Rapid Read
Cleveland Clinic CEO Highlights AI's Role in Reshaping U.S. Health Care System

Cleveland Clinic CEO Highlights AI's Role in Reshaping U.S. Health Care System

Dr. Tom Mihaljevic, CEO of Cleveland Clinic, discussed the potential of artificial intelligence (AI) in transforming the U.S. health care system during a webinar hosted by Newsweek. Mihaljevic emphasized that AI is not a panacea for the systemic issues plaguing health care but can significantly aid in redesigning care models. He highlighted the need for substantial pre-work to harness AI's full potential, noting that the current fragmented health care landscape, with over 5,500 hospitals, many of which are under-resourced, is not conducive to maximizing AI benefits. The Cleveland Clinic has been restructuring its operations to integrate AI effectively, recruiting digital leaders from outside the health care sector to drive innovation.
Trendline Trendline
Koda Health Secures Investment to Scale AI-Enhanced Advance Care Planning

Koda Health Secures Investment to Scale AI-Enhanced Advance Care Planning

Koda Health Secures Investment to Scale AI-Enhanced Advance Care Planning
Rapid Read Rapid Read
Cleveland Clinic CEO Advocates for System Overhaul to Maximize AI in Healthcare

Cleveland Clinic CEO Advocates for System Overhaul to Maximize AI in Healthcare

Dr. Tom Mihaljevic, President and CEO of Cleveland Clinic, emphasized the need for a comprehensive overhaul of the U.S. healthcare system to effectively integrate artificial intelligence (AI). During a conversation at Newsweek’s 'AI Agenda' webinar series, Mihaljevic highlighted that AI alone cannot resolve the systemic issues plaguing healthcare. He argued that the fragmented nature of the U.S. healthcare system, with over 5,500 hospitals, many of which are small and under-resourced, poses significant challenges to leveraging AI for improved healthcare delivery. Mihaljevic pointed out that most hospitals lack robust cybersecurity capabilities, making them vulnerable to cyberattacks, especially as AI tools become more advanced. He believes that AI has the potential to democratize exceptional care by being geography agnostic, but it requires a unified approach to healthcare delivery.
Rapid Read Rapid Read
Utah Medical Licensing Board Calls for Suspension of AI Prescribing Pilot

Utah Medical Licensing Board Calls for Suspension of AI Prescribing Pilot

The Utah Medical Licensing Board has urged the state to suspend a pilot program involving Doctronic, an AI-powered system for automating prescription renewals. The board expressed concerns about patient safety, as the system allows for nearly instant renewals of routine medications without direct physician oversight. The pilot, launched in January, is the first test of AI as an autonomous clinical decision-maker under a regulatory suspension paradigm. The board argues that prescription refills require clinical reassessment to ensure safety and efficacy, and that the current system may lead to outdated or suboptimal therapy for patients.
Rapid Read Rapid Read
AI Integration in Medicare Claims Raises Concerns Over Denial Rates and Bias

AI Integration in Medicare Claims Raises Concerns Over Denial Rates and Bias

The Centers for Medicare and Medicaid Services (CMS) has launched the Wasteful and Inappropriate Service Reduction (WISeR) Model, a six-year pilot program utilizing artificial intelligence (AI) to manage prior authorizations for 17 procedures across six states. This initiative aims to reduce Medicare spending by curbing fraud and unnecessary services. However, the program has raised concerns due to its profit-driven incentives and potential algorithmic bias. AI-assisted reviews have resulted in significantly higher denial rates compared to human-only reviews, with marginalized populations potentially facing disparate outcomes. The lack of transparency in AI decision-making processes further complicates the issue, as there is no federal mandate requiring insurers to disclose when an algorithm influences a denial.
Trendline Trendline
FDA Initiates AI-Driven Pilot to Accelerate Clinical Trials

FDA Initiates AI-Driven Pilot to Accelerate Clinical Trials

FDA Initiates AI-Driven Pilot to Accelerate Clinical Trials
Rapid Read Rapid Read
Decoy Therapeutics to Showcase Peptide Therapeutics at Boston Conferences

Decoy Therapeutics to Showcase Peptide Therapeutics at Boston Conferences

Decoy Therapeutics, a preclinical-stage biotechnology company, will present at two peptide therapeutics conferences in Boston. The company will discuss its Designable Multi-Antivirals (D-MAVs) platform, which uses proprietary peptide conjugates to target shared viral mechanisms. Chief Business Officer Peter Marschel will lead a roundtable on computational peptide design, while Chief Scientific Officer Dr. Barbara Hibner and Chief Technology Officer Dr. Michael Lipp will present on peptide conjugate antiviral therapeutics. The presentations will highlight Decoy's strategic partnership with Quantori and its AI-driven peptide design platform.
Rapid Read Rapid Read
AI's Role in Medicine: Balancing Innovation with Regulation

AI's Role in Medicine: Balancing Innovation with Regulation

A recent opinion piece highlights the transformative potential of artificial intelligence (AI) in democratizing healthcare access, particularly for underserved patients. The article discusses the rapid integration of AI in medical practices, where AI tools are increasingly used for routine prescriptions and minor medical conditions. However, the piece emphasizes the urgent need for robust regulation to ensure patient safety, as AI's role in medicine continues to expand. States like New York and California are taking different regulatory approaches, with New York considering legislation that could restrict AI's medical applications, while California mandates disclosure when AI is involved in patient care. The federal government is also involved, with the FDA updating its guidelines to allow certain AI tools to operate with less oversight when assisting doctors.
Rapid Read Rapid Read
U.S. Hospitals Implement AI Chatbots Amidst Doctor Concerns Over Patient Safety

U.S. Hospitals Implement AI Chatbots Amidst Doctor Concerns Over Patient Safety

Healthcare systems in the U.S. are increasingly deploying AI chatbots to assist patients with medical inquiries and appointment scheduling. Hartford HealthCare in Connecticut has introduced Patient GPT, while Sutter Health and Reid Health have launched Emmie, a chatbot integrated with Epic's MyChart. These tools aim to provide quick health guidance, especially in underserved rural areas where healthcare messages are frequent. Despite their potential to reduce waiting times and improve accessibility, there is a division among doctors regarding their safety and effectiveness. Some experts, like Nigam Shah from Stanford University, view these tools as beneficial for bridging care gaps outside clinic hours. However, concerns remain about the accuracy and monitoring of these AI systems, as highlighted by Suchi Saria from Johns Hopkins University.
Rapid Read Rapid Read
Stanford Study Highlights AI's Role in Enhancing Medical Decision-Making

Stanford Study Highlights AI's Role in Enhancing Medical Decision-Making

A Stanford Medicine-led study explores the integration of artificial intelligence (AI) in clinical decision-making, revealing its potential to enhance physician performance. The study, involving 70 physicians, examined how AI can be used as a decision support tool in medical case evaluations. The findings indicate that when AI and physicians work in parallel, the collaboration leads to more effective decision-making compared to traditional methods. This approach shifts the perception of AI from a diagnostic tool to an active clinical collaborator, facilitating richer dialogue between human insight and machine calculation.